Mixed Chimeric Transplantation for Primary Amyloidosis

Stanford University

Status: Withdrawn

Conditions: Amyloidosis

Treatments: Procedure: autologous followed by nonmyeloablative allogeneic transplant

Study type: Interventional

Funder types: Other

Identifiers

NCT00186095

BMT129

Details and patient eligibility

About

To evaluate the role of nonmyeloablative allogeneic transplantation in Amyloidosis.

Sex: All

Ages: Under 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• primary amyloidosis
• adequate organ function
• matched sibling donor

Exclusion criteria

• evidence of multiple myeloma
• HIV positive

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)